Stay updated on Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a Revision: v3.3.4 and removed Revision: v3.3.3. This appears to be a metadata/version update with no impact on the study details or user actions.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedResults posting dates and status were added (e.g., Results First Submitted/Posted dates) and a study protocol/SAP PDF was linked; several outcome items were revised or removed in the results section (e.g., Two-year Progression Free Survival and mucositis-related adverse events).SummaryDifference3%

- Check25 days agoChange DetectedFooter revision tag updated to 'Revision: v3.3.3'. The HHS Vulnerability Disclosure link was removed, along with the previous 'Revision: v3.3.2' entry.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page. No study details or eligibility criteria appear to be affected.SummaryDifference0.1%

- Check61 days agoChange DetectedDeletion of a government funding status notice from the page; no core study content such as eligibility criteria, outcomes, or locations was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedThe page content is unchanged aside from a refreshed last update timestamp in the Study Record Dates. No changes to eligibility, interventions, or outcomes are observed.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Nasopharyngeal Cancer Clinical Trial page.